HCG
GILD icon

Haven Capital Group’s Gilead Sciences GILD Stock Holding History

Haven Capital Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Hold
2,730
– – 0.28% 30
2026
Q1 		$380K Hold
2,730
– – 0.35% 28
2025
Q4 		$335K Sell
2,730
-1,257
-32% -$153K 0.31% 28
2025
Q3 		$443K Hold
3,987
– – 0.39% 28
2025
Q2 		$442K Sell
3,987
-323
-7% -$34.4K 0.39% 31
2025
Q1 		$483K Sell
4,310
-315
-7% -$32.5K 0.53% 27
2024
Q4 		$427K Buy
+4,625
New +$416K 0.4% 30

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Haven Capital Group's GILD Position: Q2 2026 in Review

Haven Capital Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,730 shares worth $345K. The position accounts for 0.28% of the portfolio, ranked #30.

Haven Capital Group first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $483K in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Haven Capital Group held 2,730 shares of Gilead Sciences worth $345K as of Q2 2026.
  • Haven Capital Group left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.28% of Haven Capital Group's portfolio in Q2 2026, its #30 holding.
  • Haven Capital Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Haven Capital Group's Gilead Sciences position peaked at $483K in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Haven Capital Group's 13F filing for Q2 2026, filed 10 Jul 2026.